Jianxin Pang

17PUBLICATIONS
15CO-AUTHORS
Wastewater treatment processesHaematologyBiologically active moleculesPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 10, 2026
Rational Design of Azaindole Derivatives via a Nitrogen-Walk Strategy from β-Carboline: Discovery of Highly Selective, Low-Toxicity URAT1 Inhibitors as Potent Urate-Lowering Agents.

|Aug 03, 2026
Isobavachin Attenuates Renal and Cardiac Injury in Chronic Hyperuricemia via Modulation of NF-κB and NLRP3 Signaling Pathways.

|May 26, 2026
Pyridoimidazolyl Sulfonamide Compound 2: A Superior Dual-Acting Drug Candidate with Potent URAT1 Inhibition and Anti-Inflammatory Activity for Gout Management.

|May 06, 2026
Discovery of a Novel Thienopyrimidine Derivative as a Potent Dual URAT1/GLUT9 Inhibitor with Enhanced Urate-Lowering Efficacy, Superior Pharmacokinetics, and Favorable Safety Profile for Gout and Hyperuricemia.

|Apr 17, 2026
A Novel Pyrrole Acylsulfonamide, Compound 42, as a Dual URAT1/GLUT9 Inhibitor: Potent Urate-Lowering Efficacy, Reduced Off-Target Effects, and Promising Druggability for Hyperuricemia.

|Jan 09, 2026
Isobavachin Ameliorates Acetaminophen-Induced Liver Injury Through Modulation of CYP2E1-Mediated Bioactivation and NRF2/PI3K/AKT Cytoprotective Pathways.

Wenjie Ye, Shuaishuai Zhang, Youxi Zhou

Pageof 3

Frequent Collaborators

7 joint publications

Peng Zhan

6 joint publications

Xinyong Liu

2 joint publications

Xiaodong Tang

2 joint publications

Shuaishuai Zhang